大鼠肝移植术后早期肝脏损害与Ref-1蛋白的表达  

Graft injury and expression of redox factor-1 during early period after liver transplantation in rats

作　　者：刘兴凯[1] 杜晓宏[1] 李开良[1] 綦俊[1] 张平[1] 

机构地区：[1]吉林大学第一医院肝胆外科,长春130021

出　　处：《中华普通外科杂志》2010年第10期826-828,共3页Chinese Journal of General Surgery

基　　金：吉林省科技发展计划项目（200705131）

摘　　要：目的 观察大鼠肝移植术后早期肝组织内氧化还原因子1（redox factor-1,Ref-1）蛋白表达与肝脏损伤的关系.方法 将150只Wistar大鼠动物分为三个组,肝移植组、假手术组和空白对照组.分别于肝移植术后3、6、9、12、24 h取材,采用免疫组织化学方法检测移植后各时间肝组织Ref-1蛋白表达,同时通过血清生化指标、组织病理学分析研究Ref-1蛋白表达的意义.结果 血清学检查显示,肝移植术后3 h AST、ALT显著升高,术后6 h降低.病理学分析显示：术后24 h内,部分肝组织结构不清,肝细胞变性,肝窦扩张充血,炎细胞明显浸润.肝损伤较重.免疫组化检测显示,肝移植后早期肝实质细胞内Refl蛋白增高.9h达高峰,以后逐渐下降.结论 肝移植术后发生肝损伤以术后6 h为最重,之后损伤程度逐渐减轻,这是由于移植术后缺血再灌注损伤,激活Ref-1的表达明显增加,修复了由于缺血再灌注损伤导致的细胞凋亡.Objective To study the relationship between graft injury and expression of redox factor-1 in early period after liver transplantation in rats. Methods One hundred and fifty adult male Wistar rats were randomly divided into three groups： liver transplant group, sham surgery group and control group. Animals were sacrificed in each group at different time points： 3,6,9, 12,24 hour after liver transplantation. The changes and significance of the expression of Ref-1 were explored by immunohistochemistry, serology and histopathology. Results Compared with sham surgery group and control group, the expression of Ref-1 protein in transplant group was higher than that in other two groups in early period after liver transplantation （ P 〈 0. 05 ）. In pathology there were lots of inflammation cells infiltration around the portal veins, and cell damage of hepatic tissue, while that in sham surgery and control group was comparatively slight. Serum ALT and AST values reached the peak at 6 ～ 12 h, and decreaced significantly after 12 h （ P 〈 0. 05 ）. Conclusions Graft injury after liver transplantation during early period reaches peak at 6 hour and then decreased. Hepatic ischemic reperfusion injury promotes Ref-1 expression, which in turn compensates for programme cell death induced by the injury.

关 键 词：肝移植 基因表达 Ref-1蛋门 肝损害 

分 类 号：R686[医药卫生—骨科学]